3/13/2025 - FDA Issues Clearance for ReWalk 7 Exoskeleton

3/7/2025 - Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

3/6/2025 - Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton

3/5/2025 - Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

3/4/2025 - headline - HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and maintains $9 price target.

3/3/2025 - Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results

2/28/2025 - Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

2/24/2025 - Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow

2/20/2025 - headline only - Lake Street analyst Ben Haynor maintains Lifeward (NASDAQ:LFWD) with a Buy and lowers the price target from $6 to $4.5

2/20/2025 - headline - HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Lifeward (NASDAQ:LFWD) with a Buy and maintains $13 price target.

2/19/2025 - Lifeward Announces CEO Transition

2/10/2025 - NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry

2/10/2025 - Laidlaw sets Lifeward stock with a Buy rating, $10 target

2/5/2025 - Lake Street Sticks to Its Buy Rating for Rewalk Robotics (LFWD), with a price target of $6.00

2/5/2025 - Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany

2/4/2025 - Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025, beginning at 10:00 am EST

1/19/2025 - When Can We Expect A Profit From Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)?

1/13/2025 - Investor Presentation

1/13/2025 - Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

1/13/2025 - Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results

1/13/2025 - Lifeward Cancels Its Extraordinary General Meeting of Shareholders

1/12/2025 - 10 Cheap Robotics Stocks To Invest In Now

1/10/2025 - Robotic exoskeleton tech helps Pittsburgh rehab patients take a big step forward

1/8/2025 - Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

1/7/2025 - Lifeward Announces $5 Million ($2.75 per share) Registered Direct Offering Priced At-the-Market Under Nasdaq Rules